Valuation Ironwood Pharmaceuticals, Inc.

Stocks

Real-time Estimate Cboe BZX 19:32:34 28/10/2026 GMT			5-day change	1st Jan Change
3.595 ^USD	+2.42%		+0.99%	+6.38%

10-16	Ironwood Pharmaceuticals, Inc. Announces CEO Changes, Effective January 1, 2027	CI
10-16	Ironwood Pharmaceuticals, Inc. Appoints Tammi Gaskins as Member of the Board of Directors, Effective January 1, 2027	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,908	1,901	1,786	708.9	548.2	580	-	-
Change	-	-0.4%	-6.02%	-60.31%	-22.67%	5.79%	-	-
Enterprise Value (EV)	1,742	1,641	1,786	708.9	548.2	580	580	580
Change	-	-5.83%	8.87%	-60.31%	-22.67%	5.79%	0%	0%
P/E	3.63x	12.9x	-1.77x	443x	22.5x	2.87x	2.67x	2.45x
PBR	3.12x	3.54x	-	-	-	-	-	-
PEG	-	-0.2x	0x	-4x	0x	0x	0.35x	0.28x
Capitalization / Revenue	4.61x	4.63x	4.03x	2.02x	1.85x	1.23x	1.17x	1.16x
EV / Revenue	0x	0x	0x	0x	0x	1.23x	1.17x	1.16x
EV / EBITDA	0x	0x	-0x	0x	0x	1.74x	1.69x	1.62x
EV / EBIT	0x	0x	-0x	0x	0x	1.83x	1.89x	1.84x
EV / FCF	0x	0x	0x	0x	0x	2.78x	2.16x	2.09x
FCF Yield	13.7%	14.4%	10.3%	14.6%	23.2%	36%	46.3%	47.9%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	3.21	0.96	-6.45	0.01	0.15	1.223	1.317	1.43
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	413.8	410.6	442.7	351.4	296.2	471.4	494	500.5
EBITDA ¹	233.7	251.8	-884.8	100.6	138.1	334.2	343.4	358.8
EBIT ¹	232.2	250.3	-945.4	94.85	98.5	316.8	307.6	315.5
Net income ¹	528.4	175.1	-1,002	1.813	24.02	203.3	219.9	240.7
Net Debt	-165.9	-260	-	-	-	-	-	-
Reference price ²	11.660	12.390	11.440	4.430	3.370	3.510	3.510	3.510
Nbr of stocks (in thousands)	163,650	153,395	156,129	160,028	162,679	165,240	-	-
Announcement Date	17/02/22	16/02/23	15/02/24	27/02/25	25/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IRONWOOD PHARMACEUTICALS, INC.	2.87x	-	-	-	580M
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,143B
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	647B
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	506B
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	384B
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	350B
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	293B
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	265B
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	242B
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	197B
Average	26.91x	7.09x	18.77x	2.12%	402.81B
Weighted average by Cap.	35.27x	8.35x	20.48x	1.8%